Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Henan Cancer Hospital

Henan Cancer Hospital in Zhengzhou, China is listed as a site for 193 registered clinical trials, 118 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 193
Ongoing 118

This page covers the site record Henan Cancer Hospital in Zhengzhou, China: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Henan Cancer Hospital, also sponsors trials.

Get the Henan Cancer Hospital report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 193 trials counted.

  • Phase 1 11 trials
  • Phase 1/2 26 trials
  • Phase 2 39 trials
  • Phase 2/3 7 trials
  • Phase 3 90 trials
  • Phase 4 3 trials
  • Observational 17 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 118 trials
  • Completed 46 trials
  • Terminated 9 trials
  • Other 20 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Observational

Top of scale: 29

2011: 1 trials (Observational 1) 2013: 3 trials (Observational 1, Phase 3 1, Phase 2 1) 2014: 1 trials (Phase 3 1) 2015: 1 trials (Phase 1/2 1) 2016: 7 trials (Phase 3 6, Phase 2 1) 2017: 10 trials (Phase 4 1, Phase 3 6, Phase 2/3 1, Phase 1/2 1, Phase 1 1) 2018: 13 trials (Observational 2, Phase 3 6, Phase 2/3 1, Phase 2 3, Phase 1 1) 2019: 7 trials (Observational 2, Phase 4 1, Phase 3 1, Phase 2/3 1, Phase 1/2 1, Phase 1 1) 2020: 19 trials (Observational 1, Phase 3 12, Phase 2/3 1, Phase 2 4, Phase 1/2 1) 2021: 26 trials (Phase 3 14, Phase 2 7, Phase 1/2 3, Phase 1 2) 2022: 29 trials (Observational 1, Phase 3 12, Phase 2/3 1, Phase 2 7, Phase 1/2 5, Phase 1 3) 2023: 23 trials (Observational 4, Phase 3 10, Phase 2 6, Phase 1/2 3) 2024: 18 trials (Observational 1, Phase 3 8, Phase 2 4, Phase 1/2 3, Phase 1 2) 2025: 22 trials (Observational 3, Phase 3 8, Phase 2/3 2, Phase 2 3, Phase 1/2 5, Phase 1 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 13
2025 22
2024 18
2023 23
2022 29
2021 26
2020 19
2019 7
2018 13
2017 10

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.